Literature DB >> 29939423

Emerging areas of opioid pharmacology.

Eamonn Kelly1, Graeme Henderson1, Chris P Bailey2.   

Abstract

This themed section of the British Journal of Pharmacology stems from an International Narcotics Research Conference (INRC) meeting held in July 2016 at The Assembly Rooms in Bath, UK. LINKED ARTICLES: This article is part of a themed section on Emerging Areas of Opioid Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.14/issuetoc.
© 2018 The British Pharmacological Society.

Mesh:

Substances:

Year:  2018        PMID: 29939423      PMCID: PMC6016631          DOI: 10.1111/bph.14343

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

Review 1.  Allostery at opioid receptors: modulation with small molecule ligands.

Authors:  Kathryn E Livingston; John R Traynor
Journal:  Br J Pharmacol       Date:  2017-06-07       Impact factor: 8.739

Review 2.  Insights into the function of opioid receptors from molecular dynamics simulations of available crystal structures.

Authors:  Kristen A Marino; Yi Shang; Marta Filizola
Journal:  Br J Pharmacol       Date:  2017-04-12       Impact factor: 8.739

Review 3.  Predictive mechanisms linking brain opioids to chronic pain vulnerability and resilience.

Authors:  Anthony Kenneth Peter Jones; Christopher Andrew Brown
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

4.  Antidepressant-like effects of BU10119, a novel buprenorphine analogue with mixed κ/μ receptor antagonist properties, in mice.

Authors:  Abdulrahman Almatroudi; Mehrnoosh Ostovar; Christopher P Bailey; Stephen M Husbands; Sarah J Bailey
Journal:  Br J Pharmacol       Date:  2017-11-06       Impact factor: 8.739

5.  In vitro and in vivo characterization of the bifunctional μ and δ opioid receptor ligand UFP-505.

Authors:  N Dietis; H Niwa; R Tose; J McDonald; V Ruggieri; M Filaferro; G Vitale; L Micheli; C Ghelardini; S Salvadori; G Calo; R Guerrini; D J Rowbotham; D G Lambert
Journal:  Br J Pharmacol       Date:  2018-05-14       Impact factor: 8.739

Review 6.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

Review 7.  Opioid and hypocretin neuromodulation of ventral tegmental area neuronal subpopulations.

Authors:  Taylor S Thomas; Corey Baimel; Stephanie L Borgland
Journal:  Br J Pharmacol       Date:  2017-09-26       Impact factor: 8.739

Review 8.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 9.  Influence of opioids on immune function in patients with cancer pain: from bench to bedside.

Authors:  Jason W Boland; A Graham Pockley
Journal:  Br J Pharmacol       Date:  2017-07-23       Impact factor: 8.739

Review 10.  Targeting multiple opioid receptors - improved analgesics with reduced side effects?

Authors:  Thomas Günther; Pooja Dasgupta; Anika Mann; Elke Miess; Andrea Kliewer; Sebastian Fritzwanker; Ralph Steinborn; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2017-05-26       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.